Esparin
Brand names,
Esparin
Analogs
Esparin
Brand Names Mixture
Esparin
Chemical_Formula
C17H20N2S
Esparin
RX_link
No information avaliable
Esparin
fda sheet
Esparin
msds (material safety sheet)
Esparin
Synthesis Reference
No information avaliable
Esparin
Molecular Weight
284.42 g/mol
Esparin
Melting Point
< 25 oC
Esparin
H2O Solubility
14.2 mg/L
Esparin
State
Liquid
Esparin
LogP
4.893
Esparin
Dosage Forms
Tablet; Oral liquid; Injection
Esparin
Indication
Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
Esparin
Pharmacology
Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.
Esparin
Absorption
Absorption may be erratic and peak plasma concentrations show large interindividual differences.
Esparin
side effects and Toxicity
Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.
Esparin
Patient Information
No information avaliable
Esparin
Organisms Affected
Humans and other mammals